Agilent Technologies Extends Biopharma Portfolio with Advanced Mass Spec System

News   Mar 09, 2017

 
Agilent Technologies Extends Biopharma Portfolio with Advanced Mass Spec System
 
 
 
 

RELATED ARTICLES

Freedom of Information Request Reveals Benefits of Blocked MS Drug

News

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

READ MORE

ACD/Labs Collaboration Provides NMR Data to Brazilian Biodiversity Natural Products Database

News

ACD/Labs announces collaboration with researchers at Brazilian Biodiversity database in support of chemical and pharmaceutical R&D.

READ MORE

Specific Gene Combinations Linked to Glioblastoma

News

A Yale-led team of researchers has identified specific gene combinations that can cause the deadly brain cancer glioblastoma, using new technology that can also pinpoint triggers of other types cancers.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE